Works matching AU Yin, Yongmei

Results: 104

Pretreatment neutrophil-to-lymphocyte ratio in peripheral blood was associated with pulmonary tuberculosis retreatment.

Published in:

2017

By:

Yongmei Yin;
Shougang Kuai;
Jun Liu;
Ying Ying Zhang;
Zhongbao Shan;
Lan Gu;
Qiusheng Huang;
Hao Pei;
Jun Wang;
Yin, Yongmei;
Kuai, Shougang;
Liu, Jun;
Zhang, YingYing;
Shan, Zhongbao;
Gu, Lan;
Huang, Qiusheng;
Pei, Hao;
Wang, Jun

Publication type:

journal article

A case of intimal sarcoma of the pulmonary artery successfully treated with chemotherapy.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 5, p. 522, doi. 10.1007/s10147-011-0338-8

By:

Xu, Yanjie;
Wang, Kai;
Geng, Yiting;
Shao, Yongfeng;
Yin, Yongmei

Publication type:

Article

JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12.

Published in:

Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00693-9

By:

Liang, Yan;
Qian, Chao;
Xie, Yinghong;
Huang, Xiang;
Chen, Junjie;
Ren, Yanlin;
Fu, Ziyi;
Li, Yongfei;
Zeng, Tianyu;
Yang, Fan;
Zhou, Jianwei;
Li, Wei;
Yin, Yongmei;
Wang, Changqing

Publication type:

Article

Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti‐angiogenic Therapy in Armored and Cold Tumors.

Published in:

Advanced Science, 2025, v. 12, n. 10, p. 1, doi. 10.1002/advs.202409147

By:

Mei, Jie;
Yang, Kai;
Zhang, Xinkang;
Luo, Zhiwen;
Tian, Min;
Fan, Hanfang;
Chu, Jiahui;
Zhang, Yan;
Ding, Junli;
Xu, Junying;
Cai, Yun;
Yin, Yongmei

Publication type:

Article

Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2‐Positive Breast Cancer.

Published in:

Advanced Science, 2024, v. 11, n. 18, p. 1, doi. 10.1002/advs.202309424

By:

Duan, Ningjun;
Hua, Yijia;
Yan, Xueqi;
He, Yaozhou;
Zeng, Tianyu;
Gong, Jue;
Fu, Ziyi;
Li, Wei;
Yin, Yongmei

Publication type:

Article

Prospective Assessment of Pemetrexed or Pemetrexed Plus Platinum in Combination With Gefitinib or Erlotinib in Patients With Acquired Resistance to Gefitinib or Erlotinib: A Phase II Exploratory and Preliminary Study.

Published in:

Clinical Lung Cancer, 2015, v. 16, n. 2, p. 121, doi. 10.1016/j.cllc.2014.09.007

By:

Shaomin Yu;
Bin Zhang;
Chengcheng Xiang;
Yongqian Shu;
Hao Wu;
Xiang Huang;
Qianqian Yu;
Yongmei Yin;
Renhua Guo

Publication type:

Article

MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells (Review).

Published in:

Oncology Letters, 2017, v. 14, n. 5, p. 5069, doi. 10.3892/ol.2017.6867

By:

XUEMEI FAN;
WEI CHEN;
ZIYI FU;
LIHUA ZENG;
YONGMEI YIN;
HONGYAN YUAN

Publication type:

Article

Long-term remission of hormone receptor-positive/HER2-positive metastatic breast cancer due to combined treatment with everolimus/trastuzumab/exemestane: A case report.

Published in:

2017

By:

JIAN WANG;
CHUNXIAO SUN;
XIANG HUANG;
JINRONG QIU;
YONGMEI YIN

Publication type:

Case Study

Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.577150

By:

Bao, Shengnan;
Chen, Yi;
Yang, Fan;
Sun, Chunxiao;
Yang, Mengzhu;
Li, Wei;
Huang, Xiang;
Li, Jun;
Wu, Hao;
Yin, Yongmei

Publication type:

Article

The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.

Published in:

Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 6, p. 1057, doi. 10.1007/s00432-012-1179-1

By:

Zhang, Jinying;
Zhu, Lingjun;
Wei, Juan;
Liu, Lingxiang;
Yin, Yongmei;
Gu, Yanhong;
Shu, Yongqian

Publication type:

Article

The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data.

Published in:

BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/763080

By:

Wang, Yang;
Gao, Wen;
Xu, Jiali;
Chen, Xiaojun;
Yang, Yang;
Zhu, Yizhi;
Yin, Yongmei;
Guo, Renhua;
Liu, Ping;
Shu, Yongqian;
Liu, Lingxiang

Publication type:

Article

MiR‐326/Sp1/KLF3: A novel regulatory axis in lung cancer progression.

Published in:

Cell Proliferation, 2019, v. 52, n. 2, p. N.PAG, doi. 10.1111/cpr.12551

By:

Wang, Rong;
Xu, Jiali;
Xu, Jing;
Zhu, Wei;
Qiu, Tianzhu;
Li, Jun;
Zhang, Meiling;
Wang, Qianqian;
Xu, Tongpeng;
Guo, Renhua;
Lu, Kaihua;
Yin, Yongmei;
Gu, Yanhong;
Zhu, Lingjun;
Huang, Puwen;
Liu, Ping;
Liu, Lianke;
De, Wei;
Shu, Yongqian

Publication type:

Article

Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study.

Published in:

PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0095897

By:

Chen, Xiaofeng;
Zhu, Quan;
Liu, Yiqian;
Liu, Ping;
Yin, Yongmei;
Guo, Renhua;
Lu, Kaihua;
Gu, Yanhong;
Liu, Lianke;
Wang, Jinghua;
Wang, Zhaoxia;
Røe, Oluf Dimitri;
Shu, Yongqian;
Zhu, Lingjun

Publication type:

Article

Genetic Variations in the Flanking Regions of miR-101-2 Are Associated with Increased Risk of Breast Cancer.

Published in:

PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086319

By:

Chen, Jiaping;
Qin, Zhenzhen;
Jiang, Yue;
Wang, Yanru;
He, Yisha;
Dai, Juncheng;
Jin, Guangfu;
Ma, Hongxia;
Hu, Zhibin;
Yin, Yongmei;
Shen, Hongbing

Publication type:

Article

MDM2 Promotes Invasion and Metastasis in Invasive Ductal Breast Carcinoma by Inducing Matrix Metalloproteinase-9.

Published in:

PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0078794

By:

Chen, Xiaofeng;
Qiu, Jinrong;
Yang, Dapeng;
Lu, Jianlei;
Yan, Caiyun;
Zha, Xiaoming;
Yin, Yongmei

Publication type:

Article

Genetic Variation in a MicroRNA-502 Minding Site in SET8 Gene Confers Clinical Outcome of Non-Small Cell Lung Cancer in a Chinese Population.

Published in:

PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077024

By:

Xu, Jiali;
Yin, Zhiqiang;
Gao, Wen;
Liu, Lingxiang;
Yin, Yongmei;
Liu, Ping;
Shu, Yongqian

Publication type:

Article

MicroRNA-34a Mediates the Autocrine Signaling of PAR2-Activating Proteinase and Its Role in Colonic Cancer Cell Proliferation.

Published in:

PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072383

By:

Ma, Yiming;
Bao-Han, Wuyun;
Lv, Xue;
Su, Yuntao;
Zhao, Xinhua;
Yin, Yongmei;
Zhang, Xingmao;
Zhou, Zhixiang;
MacNaughton, Wallace K.;
Wang, Hongying

Publication type:

Article

Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk

Published in:

PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063654

By:

Xu, Jiali;
Yin, Zhiqiang;
Cao, Songyu;
Gao, Wen;
Liu, Lingxiang;
Yin, Yongmei;
Liu, Ping;
Shu, Yongqian

Publication type:

Article

Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review.

Published in:

PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059314

By:

Chen, Xiaofeng;
Liu, Yiqian;
Røe, Oluf Dimitri;
Qian, Yingying;
Guo, Renhua;
Zhu, Lingjun;
Yin, Yongmei;
Shu, Yongqian

Publication type:

Article

Clinical, pathological and gene expression profiling of estrogen receptor discordance in breast cancer.

Published in:

Clinical & Translational Oncology, 2025, v. 27, n. 1, p. 233, doi. 10.1007/s12094-024-03547-9

By:

Wang, Xi;
Bao, Shengnan;
Jiang, Mengping;
Zou, Xian;
Yin, Yongmei

Publication type:

Article

EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties.

Published in:

FASEB Journal, 2019, v. 33, n. 4, p. 4851, doi. 10.1096/fj.201701561RRRR

By:

Yongfei Li;
Jiahui Chu;
Wanting Feng;
Mengzhu Yang;
Yanhong Zhang;
Yanqiu Zhang;
Ye Qin;
Juan Xu;
Jun Li;
Vasilatos, Shauna N.;
Ziyi Fu;
Yi Huang;
Yongmei Yin

Publication type:

Article

Efficacy and safety of denosumab versus zoledronic acid for treatment of bone metastasis in breast cancer patients: a propensity score-matched cohort study.

Published in:

Journal of Practical Oncology, 2024, v. 39, n. 6, p. 542, doi. 10.13267/j.cnki.syzlzz.2024.080

By:

Huang Xiang;
Liu Qian;
Wu Xinyu;
Jin Nan;
Yin Yongmei

Publication type:

Article

Update and interpretation of CSCO guidelines in 2023: HER2-positive advanced breast cancer.

Published in:

Journal of Practical Oncology, 2023, v. 38, n. 6, p. 505, doi. 10.13267/j.cnki.syzlzz.2023.079

By:

Sun Chunxiao;
Huang Xiang;
Li Wei;
Yin Yongmei

Publication type:

Article

Update on endocrine stratified therapy for advanced breast cancer.

Published in:

Journal of Practical Oncology, 2023, v. 38, n. 2, p. 105, doi. 10.13267/j.cnki.syzlzz.2023.018

By:

Yan Xueqi;
Huang Xiang;
Li Wei;
Yin Yongmei

Publication type:

Article

Efficacy and safety of RC48-ADC in HER2-positive and HER2-low metastatic breast cancer: a multicenter, real-world study.

Published in:

Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1435485

By:

Qu, Fei;
Lu, Rongrong;
Wu, Xinyu;
Liu, Qian;
Zha, Mengyao;
Li, Huihui;
Yuan, Yuan;
Han, Zhengxiang;
Cai, Dongyan;
Huang, Xiang;
Yin, Yongmei;
Li, Wei

Publication type:

Article

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.

Published in:

Drug Design, Development & Therapy, 2016, v. 10, p. 241, doi. 10.2147/DDDT.S88743

By:

Jing Qian;
Yingying Qian;
Jian Wang;
Bing Gu;
Dong Pei;
Shaohua He;
Fang Zhu;
Røe, Oluf Dimitri;
Jin Xu;
Lianke Liu;
Yanhong Gu;
Renhua Guo;
Yongmei Yin;
Yongqian Shu;
Xiaofeng Chen

Publication type:

Article

Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 5, p. 1287, doi. 10.1007/s00280-013-2127-8

By:

Zhao, Wan;
Hu, Lingmin;
Xu, Jiali;
Shen, Hongbing;
Hu, Zhibin;
Ma, Hongxia;
Shu, Yongqian;
Shao, Yongfeng;
Yin, Yongmei

Publication type:

Article

Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2016, v. 38, n. 5, p. 1003, doi. 10.1159/000443052

By:

Aiyu Zhu;
Yan Li;
Wei Song;
Yumei Xu;
Fang Yang;
Wenwen Zhang;
Yongmei Yin;
Xiaoxiang Guan

Publication type:

Article

Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2016, v. 38, n. 3, p. 1003, doi. 10.1159/000443052

By:

Zhu, aiyu;
Li, Yan;
Song, Wei;
Xu, Yumei;
Yang, Fang;
Zhang, Wenwen;
Yin, Yongmei;
Guan, Xiaoxiang

Publication type:

Article

High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in triple-negative breast cancer.

Published in:

NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00618-6

By:

Mei, Jie;
Cai, Yun;
Zhu, Hongjun;
Jiang, Ying;
Fu, Ziyi;
Xu, Junying;
Chen, Lingyan;
Yang, Kai;
Zhao, Jinlu;
Song, Chenghu;
Zhang, Yan;
Mao, Wenjun;
Yin, Yongmei

Publication type:

Article

BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1.

Published in:

Scientific Reports, 2016, p. 22034, doi. 10.1038/srep22034

By:

Zhang, Wenwen;
Luo, Jiayan;
Yang, Fang;
Wang, Yucai;
Yin, Yongmei;
Strom, Anders;
Gustafsson, Jan Åke;
Guan, Xiaoxiang

Publication type:

Article

Interference-Free Surface-Enhanced Raman Scattering Tags for Single-Cell Molecular Imaging with a High Signal-to-Background Ratio.

Published in:

Small, 2017, v. 13, n. 15, p. n/a, doi. 10.1002/smll.201603340

By:

Ma, Sisi;
Li, Qiang;
Yin, Yongmei;
Yang, Jie;
Liu, Dingbin

Publication type:

Article

Gold Nanoparticles: Interference-Free Surface-Enhanced Raman Scattering Tags for Single-Cell Molecular Imaging with a High Signal-to-Background Ratio (Small 15/2017).

Published in:

Small, 2017, v. 13, n. 15, p. n/a, doi. 10.1002/smll.201770083

By:

Ma, Sisi;
Li, Qiang;
Yin, Yongmei;
Yang, Jie;
Liu, Dingbin

Publication type:

Article

Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221085232

By:

Hua, Yijia;
Li, Wei;
Jin, Nan;
Cai, Dongyan;
Sun, Jie;
Sun, Chunxiao;
Yang, Fan;
Wu, Xinyu;
Huang, Xiang;
Wang, Biyun;
Yin, Yongmei

Publication type:

Article

Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01949-z

By:

Yan, Xueqi;
Xie, Yinghong;
Yang, Fan;
Hua, Yijia;
Zeng, Tianyu;
Sun, Chunxiao;
Yang, Mengzhu;
Huang, Xiang;
Wu, Hao;
Fu, Ziyi;
Li, Wei;
Jiao, Shiping;
Yin, Yongmei

Publication type:

Article

Which Has a Greater Impact on the Recurrence in Young Breast Cancer Patients: Recent Childbirth or Recent Breastfeeding?

Published in:

Breast Journal, 2022, v. 2022, p. 1, doi. 10.1155/2022/5823867

By:

Yan, Caiyun;
Bai, Jianling;
Bao, Shengnan;
Xia, Yiqin;
Yu, Hao;
Yin, Yongmei

Publication type:

Article

An Imbalance in Histone Modifiers Induces tRNA-Cys-GCA Overexpression and tRF-27 Accumulation by Attenuating Promoter H3K27me3 in Primary Trastuzumab-Resistant Breast Cancer.

Published in:

Cancers, 2024, v. 16, n. 6, p. 1118, doi. 10.3390/cancers16061118

By:

Duan, Ningjun;
Hua, Yijia;
Yan, Xueqi;
He, Yaozhou;
Zeng, Tianyu;
Gong, Jue;
Fu, Ziyi;
Li, Wei;
Yin, Yongmei

Publication type:

Article

Effectiveness and Safety of Palbociclib Plus Endocrine Therapy in Patients with Advanced Breast Cancer: A Multi-Center Study in China.

Published in:

Cancers, 2023, v. 15, n. 17, p. 4360, doi. 10.3390/cancers15174360

By:

Wu, Xinyu;
Jin, Nan;
Gao, Hongfei;
Yan, Min;
Chen, Qianjun;
Sun, Tao;
Hao, Chunfang;
Zhao, Yanxia;
Han, Xinhua;
Pan, Yueyin;
Huang, Xiang;
Li, Wei;
Wang, Kun;
Yin, Yongmei

Publication type:

Article

Exosome-Transmitted tRF-16-K8J7K1B Promotes Tamoxifen Resistance by Reducing Drug-Induced Cell Apoptosis in Breast Cancer.

Published in:

Cancers, 2023, v. 15, n. 3, p. 899, doi. 10.3390/cancers15030899

By:

Sun, Chunxiao;
Huang, Xiang;
Li, Jun;
Fu, Ziyi;
Hua, Yijia;
Zeng, Tianyu;
He, Yaozhou;
Duan, Ningjun;
Yang, Fan;
Liang, Yan;
Wu, Hao;
Li, Wei;
Zhang, Yuchen;
Yin, Yongmei

Publication type:

Article

A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Published in:

Cancers, 2022, v. 14, n. 17, p. 4084, doi. 10.3390/cancers14174084

By:

Zeng, Tianyu;
Sun, Chunxiao;
Liang, Yan;
Yang, Fan;
Yan, Xueqi;
Bao, Shengnan;
Zhang, Yucheng;
Huang, Xiang;
Fu, Ziyi;
Li, Wei;
Yin, Yongmei

Publication type:

Article

Association between survivin −31G>C promoter polymorphism and cancer risk: a meta-analysis.

Published in:

European Journal of Human Genetics, 2012, v. 20, n. 7, p. 790, doi. 10.1038/ejhg.2011.276

By:

Wang, Xiefeng;
Huang, Lili;
Xu, Yanjie;
Shi, Zhumei;
Wang, Yingyi;
Zhang, Junxia;
Wang, Xirui;
Cao, Lei;
Luo, Hui;
Chen, Jiawei;
Liu, Ning;
Yin, Yongmei;
You, Yongping

Publication type:

Article

Ratio of monocytes to lymphocytes in peripheral blood in patients diagnosed with active tuberculosis.

Published in:

Brazilian Journal of Infectious Diseases, 2015, v. 19, n. 2, p. 125, doi. 10.1016/j.bjid.2014.10.008

By:

Jun Wang;
Yongmei Yin;
Xuedong Wang;
Hao Pei;
Shougang Kuai;
Lan Gu;
Huiqin Xing;
Yu Zhang;
Qiusheng Huang;
Bin Guan

Publication type:

Article

Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 241, doi. 10.1007/s10147-024-02657-2

By:

Li, Jin;
Xue, Junli;
Liu, Tianshu;
Feng, Yi;
Xu, Nong;
Huang, Jianjin;
Yin, Yongmei;
Zhang, Jun;
Mou, Haibo;
Shentu, Jiangzhong;
Bao, Hanying;
Xu, Zusheng;
Xu, Zuhong

Publication type:

Article

Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer.

Published in:

International Journal of Clinical Oncology, 2014, v. 19, n. 2, p. 303, doi. 10.1007/s10147-013-0542-9

By:

Geng, Yiting;
Chen, Xiaofeng;
Qiu, Jinrong;
Zhou, Yue;
Wang, Jian;
Liu, Lingxiang;
Shao, Yongfeng;
Yin, Yongmei

Publication type:

Article

Disparities of Trastuzumab Use in Resource-Limited or Resource-Abundant Regions and Its Survival Benefit on HER2 Positive Breast Cancer: A Real-World Study from China.

Published in:

Oncologist, 2017, v. 22, n. 11, p. 1333, doi. 10.1634/theoncologist.2017-0088

By:

Li, Jianbin;
Wang, Shusen;
Wang, Yongsheng;
Wang, Xiaojia;
Wang, Haibo;
Feng, Jifeng;
Zhang, Qingyuan;
Sun, Tao;
Ouyang, Quchang;
Yin, Yongmei;
Liu, Yinhua;
Geng, Cuizhi;
Yan, Min;
Jiang, Zefei

Publication type:

Article

Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study.

Published in:

Cancer Medicine, 2021, v. 10, n. 23, p. 8662, doi. 10.1002/cam4.4351

By:

Bao, Shengnan;
Jiang, Mengping;
Wang, Xi;
Hua, Yijia;
Zeng, Tianyu;
Yang, Yiqi;
Yang, Fan;
Yan, Xueqi;
Sun, Chunxiao;
Yang, Mengzhu;
Fu, Ziyi;
Huang, Xiang;
Li, Jun;
Wu, Hao;
Li, Wei;
Tang, Jinhai;
Yin, Yongmei

Publication type:

Article

Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study.

Published in:

Cancer Medicine, 2021, v. 10, n. 19, p. 6744, doi. 10.1002/cam4.4215

By:

Guo, Fengzhu;
Yi, Zongbi;
Wang, Wenna;
Han, Yiqun;
Yu, Pei;
Zhang, Su;
Ouyang, Quchang;
Yan, Min;
Wang, Xiaojia;
Hu, Xichun;
Jiang, Zefei;
Huang, Tao;
Tong, Zhongsheng;
Wang, Shusen;
Yin, Yongmei;
Li, Hui;
Yang, Runxiang;
Yang, Huawei;
Teng, Yuee;
Sun, Tao

Publication type:

Article

Pamiparib dose escalation in Chinese patients with non‐mucinous high‐grade ovarian cancer or advanced triple‐negative breast cancer.

Published in:

Cancer Medicine, 2021, v. 10, n. 1, p. 109, doi. 10.1002/cam4.3575

By:

Xu, Binghe;
Yin, Yongmei;
Dong, Mei;
Song, Yan;
Li, Wei;
Huang, Xiang;
Wang, Tongshan;
He, Jing;
Mu, Xiyan;
Li, Li;
Mu, Song;
Zhang, Wa;
Li, Miao

Publication type:

Article

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer.

Published in:

Cancer Medicine, 2020, v. 9, n. 15, p. 5558, doi. 10.1002/cam4.3196

By:

Ding, Xiaorong;
Li, Yumei;
Li, Jun;
Yin, Yongmei

Publication type:

Article

Everolimus‐containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study.

Published in:

Cancer Medicine, 2019, v. 8, n. 12, p. 5544, doi. 10.1002/cam4.2460

By:

Chen, Zhanhong;
Zheng, Yabing;
Cao, Wenming;
Zhang, Yuzi;
Zhao, Zhengyi;
Wang, Guoqiang;
Zhao, Jing;
Cai, Shangli;
Shao, Xiying;
Huang, Jian;
Ye, Weiwu;
Huang, Yuan;
Li, Wei;
Huang, Xiang;
Wu, Hao;
Wang, Xiaojia;
Yin, Yongmei

Publication type:

Article